News Release

Shaping the future of phage therapy: The 7th World Conference on Targeting Phage Therapy in Malta aims to transform clinical trials through translational research

Meeting Announcement

Mitochondria-Microbiota Task Force

Targeting Phage Therapy 2024 Keynote Speech by Prof. Robert T. Schooley


It is a great pleasure to welcome Prof. Robert Schooley, from University of California, San Diego (USA) as a key note speaker during Targeting Phage Therapy 2024, this June in Malta.

view more 

Credit: Targeting Phage Therapy 2024

The 7th World Conference on Targeting Phage Therapy 2024, two-day event dedicated to advancing the field of phage research and therapy will be hosted at Corinthia Palace Malta on June 20-21.

Robert T. Schooley, M.D., Professor of Medicine at the University of California, San Diego, Co-Director of the Center for Innovative Phage Applications and Therapeutics, and member of the Executive Committee for the University of California Disaster Resilience Network, will introduce the messages and strategies behind phages therapy 2024.

His talk titled “Phage Therapeutics 2024: Essential Translational Research Components for Clinical Trials,”  will highlight the critical need for a unified approach in integrating translational research components into clinical trials to ensure their success and meaningfulness. 


The scientific commette also announces the first speakers:

1. Graham F. Hatfull, University of Pittsburgh, USA

Topic: "Mycobacteriophages and Their Therapeutic Potential"

2. Paul Turner, Yale University, USA

Topic: "Selection for Phage Resistance Reduces Virulence of Shigella flexneri"

3. Pieter-Jan Ceyssens, Sciensano, Belgium

Topic: "Quality Control of Phage Active Pharmaceutical Ingredients (APIs) in Belgium"

4. Wolfgang Weninger, Medical University of Vienna, Austria

Topic: "The Phageome in Normal and Inflamed Human Skin"

5. Sabrina Green, KU Leuven, Belgium

Topic: "Making Antibiotics Great Again: Phage Resistance in Vivo Correlates to Resensitivity to Antibiotics in Pan-Resistant Pseudomonas aeruginosa"

6. Rodrigo Ibarra Chávez, University of Copenhagen, Denmark

Topic: "Phage Satellites, a Diversity of Extradimensional Symbionts and Pathways to Phage Therapy"

7. Domenico Frezza, University of Roma Tor Vergata, Italy

Topic: "Towards Efficient Phage Therapies: Investigation of Phage/Bacteria Equilibrium with Metagenome of Dark Matter in Natural Samples"

8. Eugene V Koonin, National Institutes of Health, USA

Topic: "Evolution and Megataxonomy of Viruses: The Place of Phages in the Virosphere"

9. Federica Briani, University of Milan, Italy

Topic: "Addressing Phage Resistance to Enhance the Robustness of Phage Therapy for Pseudomonas aeruginosa Infections in Cystic Fibrosis Patients"

10. Jumpei Fujiki, University of California San Diego (USA)/ Rakuno Gakuen University (Japan)

Topic: "Phage Therapy: Targeting Intestinal Bacterial Microbiota for the Treatment of Liver Disease"


The Phage Therapy 2024 Conference promises to be a dynamic event, providing invaluable insights into the future of phage research and therapy.

For more information about Targeting Phage Therapy 2024, please visit:

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.